YD Bio Limited Ordinary Shares

YD Bio Limited Ordinary Shares

Share · KYG983011076 · YDES (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of YD Bio Limited Ordinary Shares
No Price
28.04.2026 20:00
Current Prices from YD Bio Limited Ordinary Shares
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
YDES
USD
28.04.2026 20:00
5,20 USD
-0,26 USD
-4,76 %
IEXG: IEX
IEX
YDES
USD
28.04.2026 19:57
5,27 USD
-0,19 USD
-3,48 %
Company Profile for YD Bio Limited Ordinary Shares Share
Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need. The company is based in Taipei, Taiwan.

Company Data

Name YD Bio Limited Ordinary Shares
Company YD Bio Limited Ordinary Shares
Symbol YDES
Website https://www.ydesgroup.com
Primary Exchange XNAS NASDAQ
ISIN KYG983011076
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO J. Douglas Ramsey Jr.,
Market Capitalization 367 Mio
Country Taiwan
Currency USD
Employees 0,0 T
Address No. 3, Xingnan St., 115001 Taipei
IPO Date 2025-08-29

Ticker Symbols

Name Symbol
NASDAQ YDES
More Shares
Investors who hold YD Bio Limited Ordinary Shares also have the following shares in their portfolio:
CITIGROUP INC 2048
CITIGROUP INC 2048 Bond
REPUBL.SERV 21/33
REPUBL.SERV 21/33 Bond